Response to Kearney et al.'s "Response to Kang et al.'s 'Efficacy of low-dose oral minoxidil in the management of anticancer therapy-induced alopecia in patients with breast cancer: A retrospective cohort study'"

Jeewoo Kang; Ji Won Lee; Ohsang Kwon

doi:10.1016/j.jaad.2024.12.023

Response to Kearney et al.'s "Response to Kang et al.'s 'Efficacy of low-dose oral minoxidil in the management of anticancer therapy-induced alopecia in patients with breast cancer: A retrospective cohort study'"

J Am Acad Dermatol. 2024 Dec 24:S0190-9622(24)03403-0. doi: 10.1016/j.jaad.2024.12.023. Online ahead of print.

Authors

Jeewoo Kang¹, Ji Won Lee¹, Ohsang Kwon²

Affiliations

¹ Department of Dermatology, Seoul National University College of Medicine, Seoul, Republic of Korea.
² Department of Dermatology, Seoul National University College of Medicine, Seoul, Republic of Korea; Laboratory of Cutaneous Aging and Hair Research, Clinical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea; Institute of Human-Environment Interface Biology, Seoul National University, Seoul, Republic of Korea. Electronic address: oskwon@snu.ac.kr.

PMID: 39725214
DOI: 10.1016/j.jaad.2024.12.023

No abstract available

Keywords: EIA; LDOM; alopecia; anticancer; anticancer therapy-induced alopecia; antineoplastic; breast cancer; chemotherapy; endocrine therapy; endocrine therapy-induced alopecia; low-dose oral minoxidil; pCIA; persistent chemotherapy-induced alopecia; topical minoxidil.

Publication types

Letter